AGR2, a potential prognostic and predictive biomarker and therapeutic to overcome drug resistance in HER2-overexpressing cancer
S Pacheco, Joaquín J. Maqueda, Carla Oliveíra, Lorraine O’Driscoll
This study identifies AGR2 as a prognostic biomarker and potential therapeutic target for overcoming drug resistance in HER2-overexpressing cancers.
bioRxiv · Jul 23, 2025 · PreprintCancer Biology